Chemotherapy in the oldest old: The feasibility of delivering cytotoxic therapy to patients 80years old and older

Smith, 2009, Future of cancer incidence in the United States: burdens upon an aging, changing nation, J Clin Oncol, 27, 10.1200/JCO.2008.20.8983 Yancik, 2005, Population aging and cancer: a cross-national concern, Cancer J, 11, 437, 10.1097/00130404-200511000-00002 USA Census Data, 2011 Canada, 2012 Lewis, 2003, Participation of patients 65 years of age or older in cancer clinical trials, J Clin Oncol, 21, 1383, 10.1200/JCO.2003.08.010 Hutchins, 1999, Underrepresentation of patients 65 years of age or older in cancer-treatment trials, N Engl J Med, 341, 2061, 10.1056/NEJM199912303412706 Murthy, 2004, Participation in cancer clinical trials: race-, sex-, and age-based disparities, JAMA, 291, 2720, 10.1001/jama.291.22.2720 Balducci, 2000, Management of cancer in the older person: a practical approach, Oncologist, 5, 224, 10.1634/theoncologist.5-3-224 Davidoff, 2010, Chemotherapy and survival benefit in elderly patients with advanced non–small-cell lung cancer, J Clin Oncol, 28, 2191, 10.1200/JCO.2009.25.4052 Asmis, 2008, Age and comorbidity as independent prognostic factors in the treatment of non–small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials group trials, J Clin Oncol, 26, 54, 10.1200/JCO.2007.12.8322 Kornblith, 2002, Survey of oncologists’ perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials, Cancer, 95, 989, 10.1002/cncr.10792 Muss, 2007, Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the Cancer and Leukemia Group B experience, J Clin Oncol, 25, 3699, 10.1200/JCO.2007.10.9710 Blanchard, 2011, Comparison of platinum-based chemotherapy in patients older and younger than 70 years: an analysis of Southwest Oncology Group Trials 9308 and 9509, J Thorac Oncol, 6, 115, 10.1097/JTO.0b013e3181fbebfd Mohile, 2013, Toxicity of bevacizumab in combination with chemotherapy in older patients, Oncologist, 18, 408, 10.1634/theoncologist.2012-0351 Creditor, 1993, Hazards of hospitalization of the elderly, Ann Intern Med, 118, 219, 10.7326/0003-4819-118-3-199302010-00011 Sager, 1996, Functional outcomes of acute medical illness and hospitalization in older persons, Arch Intern Med, 156, 645, 10.1001/archinte.1996.00440060067008 Lamont, 1983, The outcome of hospitalization for acute illness in the elderly, J Am Geriatr Soc, 31, 282, 10.1111/j.1532-5415.1983.tb04872.x Hassett, 2011, Chemotherapy-related hospitalization among community cancer center patients, Oncologist, 16, 378, 10.1634/theoncologist.2010-0354 Du, 2002, Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer, J Clin Oncol, 20, 4636, 10.1200/JCO.2002.05.088 Mohile, 2007, A pilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation, Cancer, 109, 802, 10.1002/cncr.22495 Fried, 2001, Frailty in older adults: evidence for a phenotype, J Gerontol A Biol Sci Med Sci, 56, M146, 10.1093/gerona/56.3.M146 Wilson, 2004, Frailty—and its dangerous effects—might be preventable, Ann Intern Med, 141, 489, 10.7326/0003-4819-141-6-200409210-00035 McCarthy, 2007, Frequency of risk factors that potentially increase harm from medications in older adults receiving primary care, Can J Clin Pharmacol, 3, e283 Repetto, 2002, Comprehensive geriatric assessment adds information to eastern cooperative oncology group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology study, J Clin Oncol, 20, 494, 10.1200/JCO.20.2.494 Freyer, 2005, Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study, Ann Oncol, 16, 1795, 10.1093/annonc/mdi368 Wedding, 2007, Physicians’ judgement and comprehensive geriatric assessment (CGA) select different patients as fit for chemotherapy, Crit Rev Oncol Hematol, 64, 1, 10.1016/j.critrevonc.2007.05.001 Extermann, 2005, Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG), Crit Rev Oncol Hematol, 55, 241, 10.1016/j.critrevonc.2005.06.003 Hurria, 2011, Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study, J Clin Oncol, 29, 3457, 10.1200/JCO.2011.34.7625 Extermann, 2012, Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score, Cancer, 118, 3377, 10.1002/cncr.26646 2014